We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Study of Veltuzumab (hA20) at Different Doses in Patients With ITP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00547066
Recruitment Status : Unknown
Verified March 2016 by Immunomedics, Inc..
Recruitment status was:  Active, not recruiting
First Posted : October 19, 2007
Last Update Posted : March 21, 2016
Information provided by (Responsible Party):
Immunomedics, Inc.